Practice manuals and clinical guidelines for psychedelic-assisted therapy (PAT) show varying alignment with the American Psychological Association's 2017 Multicultural Guidelines, but none offer teachable instructions for delivering culturally responsive care. This gap points to a need for more comprehensive training of PAT facilitators to ensure equitable treatment for diverse populations.
Among individuals with PTSD symptoms, preferences for MDMA-assisted therapies and standard psychotherapies vary, with many favoring less directive approaches. In an online survey, participants rated MDMA-Assisted Inner-Directed Psychotherapy as more appealing than Prolonged Exposure or Present-Centred Therapy, citing perceived efficacy and lower fear. Treatment appraisals and clinical factors shaped these preferences, highlighting the importance of aligning emerging interventions with patient expectations.